[1]张暮盈 高洁 王旭红.基于肺虚血瘀论特发性肺间质纤维化[J].陕西中医药大学学报,2020,(4):082-84.[doi:10.13424/j.cnki.jsctcm.2020.04.018]
　Zhang Muying,Gao Jie,Wang Xuhong.A Discussion of the Idiopathic Pulmonary Fibrosis Based on the Lung Deficiency and Blood Stasis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(4):082-84.[doi:10.13424/j.cnki.jsctcm.2020.04.018]
点击复制

基于肺虚血瘀论特发性肺间质纤维化()
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2020年4期
页码:
082-84
栏目:
出版日期:
2020-07-15

文章信息/Info

Title:
A Discussion of the Idiopathic Pulmonary Fibrosis Based on the Lung Deficiency and Blood Stasis
文章编号:
2096-1340(2020)04-0082-03
作者:
张暮盈 高洁 王旭红
陕西中医药大学附属医院,陕西咸阳712000
Author(s):
Zhang Muying;  Gao Jie;  Wang Xuhong
The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang Shaanx, 712000
关键词:
特发性肺纤维化; 肺虚血瘀; 肺络痹阻; 益气补肺; 活血瘀
Keywords:
IPF;  the lung deficiency and blood stasis;  the blockage of the lung collateral;  invigorate qi to tonify the lung;  activate blood to remove stasis
分类号:
R228
DOI:
10.13424/j.cnki.jsctcm.2020.04.018
文献标志码:
Ａ
摘要:
特发性肺间质纤维化是呼吸系统中较为常见的代表性疾病，其临床患病率高，病情进行性发展，愈后差。中医认为肺纤维化的病机为气虚血瘀、肺络痹阻，治疗以益气补肺、活血祛瘀为根本大法，为临床诊治提供理论依据。
Abstract:
Idiopathic Pulmonary Fibrosis, is a representative disease usually occurring to the respiratory system which is characterized by the high morbidity and disease progress and worse recovery. According to TCM, IPF is caused by the qi deficiency, blood stagnation, and the blockage of the lung collateral, therefore the treatment aims to invigorate qi and activate blood to resolve stasis. Hopefully, this paper can provide the theoretical basis for the clinical practice.

参考文献/References:

[1]郑健,朱雪,王丽琴,等.从气虚论治肺纤维化[J].中医药信息,2013,30(4):1-3.
[2]张蕾.环磷酰胺治疗特发性肺纤维化的疗效观察[J].中国医院药学杂志,2014,34(5):395-399.
[3] Wallis A, Spinks K. The diagnosis and management of interstitial lungdiseases[ J] . BMJ,2015,350( 17) : h2072.
[4]彭文苗,叶朝阳,田正鉴.田正鉴治疗肺纤维化经验[J].湖南中医杂志,2015,31(11):35-37.
[5]董梅,张念志.特发性肺纤维化中医药研究进展[J].陕西中医学院学报,2013,36(2):111-112.
[6]北京中医医院.关幼波临床经验选[M].北京:人民卫生出版社,1979.
[7]陈丽婷,陈豪,朱篧.“痰瘀互结证”辨治浅析[J].现代中医药,2012,32(4):57-58
[8]滑振,吕晓东,庞立健,等.间质性肺疾病中医证素辨证规律及特点的临床研究[J].陕西中医,2015,36(8):984-986.
[9]王飞,陈平.补阳还五汤对搏莱霉素诱导大鼠肺间质纤维化过程中TGF-β1含量的影响[J].四川中医,2005,23(9):31-32.
[10]陈宝华.补阳还五汤治疗慢性阻塞性肺疾病合并肺间质纤维化的临床观察[D].成都:成都中医药大学,2013.
[11]辛洪涛,周晓辉,柳澄,等.益气活血法治疗肺间质纤维化临床研究[J].山东医药,2014,41(24):9-11.
[12]李辉,李国勤,刘俊玲,等.益气活血通络法对特发性肺纤维化患者生存质量的影响[J].北京中医药大学学报,2010,33(3):214-216.
[13]徐飞,崔文强,董竞成,等.川芎嗪治疗特发性肺纤维化临床疗效的系统评价[J].世界中医药,2016,11(1):163-167.
[14]张翠英,章洪,戚琼华.川芎的有效成分及药理研究进展[J].辽宁中医杂志,2014,41(10):2264-2266.
[15]商宇.三七总皂苷调节小鼠上呼吸道菌群及局部免疫的实验研究[D].昆明:云南中医学院,2012.
[16]罗群,陈小波,吴璐璐,等.间质性肺疾病急性加重患者病原学检测结果分析[J].中国感染与化疗杂志,2013,13(1):31-34.

相似文献/References:

[1]张仁佳１　陈炜２.陈炜主任从虚、痰、瘀辨治特发性肺纤维化的经验[J].陕西中医药大学学报,2019,(06):060.[doi:10.13424/j.cnki.jsctcm.2019.06.016]
　Zhang Renjia,Chen Wei.Director Chen Wei’s Experience in Differentiating and Treating Idiopathic Pulmonary Fibrosis from Deficiency, Phlegm and Stasis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2019,(4):060.[doi:10.13424/j.cnki.jsctcm.2019.06.016]
[2]李莹莹１ 陈炜２.基于气血理论论治特发性肺纤维化[J].陕西中医药大学学报,2019,(02):026.[doi:10.13424/j.cnki.jsctcm.2019.02.009]
[3]胡梦娟 陈炜.特发性肺纤维化“肺失治节，因虚致瘀”病机研究[J].陕西中医药大学学报,2019,(02):029.[doi:10.13424/j.cnki.jsctcm.2019.02.010]

备注/Memo

备注/Memo:
基金项目:咸阳市二0一八年科学技术研究计划项目(2018X02-94)
更新日期/Last Update: 2020-07-15